|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1187632 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00928916.6 |
| Date of filing the European patent application | 2000-05-09 | |
| (97) | Date of publication of the European application | 2002-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2008-12-03 |
| (46) | Date of publication of the claims translation | 2009-03-25 |
| (86) | Number | PCT/US2000/012552 |
| Date | 2000-05-09 |
| (87) | Number | WO 2000/069460 |
| Date | 2000-11-23 |
| (30) | Number | Date | Country code |
| 134085 P | 1999-05-14 | US |
| (72) |
COHEN, Robert, L., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco CA 94080-4990,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Gydymas anti-ErbB2 antikūnais |
| TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2016-04-22 | 17 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2016-03-17 |